Abstract
Inhibitors of dipeptidyl peptidase-4 (DPP4) have been shown to be effective treatments for type 2 diabetes. A series of novel 1,2,3-triazole based xanthine derivatives were designed and evaluated for in vitro dipeptidyl peptidase-4 (DPP-4) activity. Among them, the representative compounds 7b, 7e, 7g and 6e showed excellent inhibitory activity of DPP-4 with IC50 values ranging from 87.41 to 16.34 nM, respectively. The SAR of these xanthine derivatives have been discussed, which would be useful for developing novel DPP-4 inhibitors as treating type 2 diabetes.
Graphic Abstract
1,2,3-triazole based xanthine derivatives were designed and evaluated for in vitro dipeptidyl peptidase-4 (DPP-4) activity. The SAR of these xanthine derivatives had been discussed, which would be useful for developing novel DPP-4 inhibitors as treating type 2 diabetes.
Similar content being viewed by others
References
American Diabetes Association 2014 Diagnosis and classification of diabetes mellitus Diabetes Care 37 Suppl 1, S81–90.
International Diabetes Federation, ‘Diabetes Estimates Excel Tables’. http://www.idf.org/diabetesatlas/diabetes-estimates-tables, cited 22 May 2012
Mclntosh C H S 2008 Dipeptidyl peptidase iv inhibitors and diabetes therapy Front. Biosci. 13 1753
Hsia S H and Davidson M B 2002 Established therapies for diabetes mellitus Curr. Med. Res. Opin. 18 S13
Verspohl E J 2009 Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors Pharmacol. Ther. 124 113
Duez H Cariou B and Staels B 2012 DPP-4 inhibitors in the treatment of type 2 diabetes Biochem. Pharmacol. 83 823
Kim D, Wang L, Beconi M and Eiermann G J et al 2005 (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluoro phenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes J. Med. Chem. 48 141
Kim D, Kowalchick J E and Brockunier L L et al 2008 Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from β-aminoamides bearing substituted Triazolopiperazines J. Med. Chem. 51 589
Villhauer E B, Brinkman J A and Naderi G B et al 2002 ‘1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties J. Med. Chem. 45 2362.
Bosi E, Camisasca R P, Collober C, Rochotte E and Garber A J 2007 Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin Diabetes Care 30 890
Fonseca V, Schweizer A, Albrecht D, Baron M A, Chang I and Dejager S 2007 Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes Diabetologia 50 1148
Augeri D J, Robl J A and Betebenner D A et al 2005 Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes J. Med. Chem. 48 5025
Feng J, Zhang Z, Wallace M B and Stafford J A et al 2007 Discovery of Alogliptin: A potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV J. Med. Chem. 50 2297
Eckhardt M, Langkop E and Mark M et al 2007 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes J. Med. Chem. 50 6450
Kuaile L, Zhengyan C, Fei W, Wei Z and Weicheng Z 2013 Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4 Chem. Pharm. Bull. 61 477
Gang L, Yi H, Baokun Y, Jin W, Qian J, Ziyun L, Zhufang S and Haihong H 2016 Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents Eur. J. Med. Chem. 124 103
Narsimha S, Kumar T R, Kumar N S, Yakub S and Reddy N V 2014 Synthesis and antibacterial activity of (1-aryl-1, 2, 3-triazol-4-yl) methyl esters of morpholine-3-carboxylic acid Med. Chem. Res. 23 5321
Narsimha S, Kumar N S, Swamy B K, Reddy N V, Althaf Hussain S K and Rao M S 2016 Indole-2-carboxylic acid derived mono and bis 1,4-disubstituted 1,2,3-triazoles: Synthesis, characterization and evaluation of anticancer, antibacterial, and DNA-cleavage activities Bioorg. Med. Chem. Lett. 26 1639
Reddy N V, Kumar N S, Narsimha S, Swamy B K, Jyostna T S and Reddy Y N 2016 Synthesis, characterization and biological evaluation of 7-substituted- 4-((1-aryl-1H-1,2,3-triazol-4-yl) methyl)-2H-benzo[b][1,4]oxazin- 3(4H)-ones as anticancer agents Med. Chem. Res. 25 1781
Kumar T R, Narsimha S, Swamy B K, Chary V R, Estari M and Reddy N V 2017 Synthesis, anticancer and antibacterial evaluation of novel (isopropylidene) uridine-[1,2,3]triazole hybrids J. Saudi Chem. Soc. 21 795
Swamy B K, Narsimha S, Kumar T R, Reddy Y N and Reddy N V 2017 Synthesis and biological evaluation of novel thiomorpholine 1,1-dioxide derived 1,2,3-triazole hybrids as potential anticancer agents Chemistry Select. 2 4001
Swamy B K, Narsimha S, Kumar T R, Reddy Y N and Reddy N V 2017 Synthesis and biological evaluation of (N‐(3‐methoxyphenyl)‐4‐((aryl‐1H‐1,2,3‐triazol‐4‐yl)methyl) thiomorpholine‐2‐ carboxamide 1,1‐Dioxide Hybrids as Antiproliferative Agents Chemistry Select. 2 9595
Sharpless K and Manetsch B R 2006 In situ click chemistry: a powerful means for lead discovery Expert Opin. Drug Discov. 1 525
Fournier D, Hoogenboom R and Schubert U S 2007 Clicking polymers: a straightforward approach to novel macromolecular architectures Chem. Soc. Rev. 36 1369
Braunschweig A B, Dichtel W R, Miljanic O S, Olson M A, Spruell J M, Khan S I, Heath J R and Stoddart J F 2007 Modular synthesis and dynamics of a variety of donor-acceptor interlocked compounds prepared by click chemistry Chem. Asian J. 2 634
Vani K V, Ramesh G and Rao C V 2016 Synthesis of new triazole and oxadiazole derivatives of quinazolin-4(3H)-one and their antimicrobial activity J. Heterocycl. Chem. 53 719
Ashok M and Holla B S 2007 Convenient synthesis of some triazolothiadiazoles and triazolothiadiazines carrying 4-methylthiobenzyl moiety as possible antimicrobial agents J. Pharmacol. Toxicol. 2 256
Swamy B K, Narsimha S, Reddy N V, Priyanka B and Rao M S 2016 Synthesis and antimicrobial evaluation of some novel thiomorpholine derived 1, 4-disubstituted 1, 2, 3-triazoles J. Serb. Chem. Soc. 81 233
Costa M S, Boechat N, Rangel E A, Silva F C, de Souza A M T, Rodrigues C R, Castro H C, Junior I N, Lourenco M C S, Wardell S M S V and Ferreira V F 2006 Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives Bioorg. Med. Chem. 14 8644
Wang G, Peng Z, Wang J, Li J and Li X 2016 Synthesis and biological evaluation of novel 2,4,5-triarylimidazole–1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors Bioorg. Med. Chem. Lett. 26 5719
Narsimha S, Kumara S B and Vasudeva R N 2018 One-pot synthesis of novel 1,2,3-triazole-pyrimido[4,5-c]isoquinoline hybrids and evaluation of their antioxidant activity Synth. Commun. 48 1220
Narsimha S, Kumaraswamy B, Kumar N S, Ramesh G, Narasimha R Y and Vasudeva R N 2016 One-pot synthesis of fused benzoxazino[1,2,3]triazolyl[4,5-c]quinolinone derivatives and their anticancer activity RSC Adv. 6 74332
Narsimha S, Kumara S B, Narasimha R Y and Vasudeva R N 2018 Microwave-assisted Cu-catalyzed C–C bond formation: one-pot synthesis of fully substituted 1,2,3-triazoles using nonsymmetrical iodoalkynes and their biological evaluation Chem. Heterocycl. Compd. 54 1161
Lazrek H B, Taourirte M, Oulih T, Barascut J L, Imbach J L, Pannecouque C, Witrouw M and De Clercq E 2001 Synthesis and anti-HIV activity of new modified 1, 2, 3-triazole acyclonucleosides Nucleos. Nucleot. Nucl. 12 1949
Costa E C, Cassamale T B, Carvalho D B, Cassemiro N S, Tomazela C C, Marques M C S, Ojeda M, Matos M F C, Albuquerque S, Baroni A C M and Arruda C C P 2016 Antileishmanial Activity and Structure-Activity Relationship of Triazolic Compounds Derived from the Neolignans Grandisin, Veraguensin, and Machilin G Molecules 21 802
Krajczyk A, Kulinska K, Kulinski T, Hurst B L, Day C W, Smee D F, Ostrowski T, Januszczyk P and Zeidler J 2014 Antivirally active ribavirin analogues – 4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling Antivir. Chem. Chemother. 23 161
Shankariah G, Jongkook L and Haeil P 2016 Novel 1,2,3‐Triazole Analogs of Sitagliptin as DPP4 Inhibitors Bull. Korean Chem. Soc. 37 1156
Qing L, Li H, Bin Z, Jinpei Z and Huibin Z 2016 Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors Org. Biomol. Chem. 14 9598
Himo F, Lovell T, Hilgraf R, Rostovtsev V V, Noodleman L, Sharpless K B and Fokin V V 2005 Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates J. Am. Chem. Soc. 127 210
Nagatsu T, Hino M, Fuyamada H, Hayakawa T, Sakakibara S, Nakagawa Y and Takemoto T 1976 New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase Anal. Biochem. 74 466
Pascual I, Lopéz A, Gómez H, Chappé M, Saroyán A, González Y, Cisneros M, Charli J L and Chávez M A 2007 Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms Enzyme Microb. Technol. 40 414
Acknowledgement
The authors are thankful to the Director of Indian Institute of Chemical Technology in Hyderabad for recording 1H, 13C NMR and mass spectra.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Narsimha, S., Battula, K.S., Ravinder, M. et al. Design, synthesis and biological evaluation of novel 1,2,3-triazole-based xanthine derivatives as DPP-4 inhibitors. J Chem Sci 132, 59 (2020). https://doi.org/10.1007/s12039-020-1760-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12039-020-1760-0